Overview


According to FutureWise analysis the market for compounding pharmacy in 2023 is US$ 9.16 billion, and is expected to reach US$ 14.85 billion by 2031 at a CAGR of 6.2%.

A pharmacy run by a licensed pharmacist, licensed physician, or someone working under a licensed pharmacist is referred to as a compounding pharmacy. It differs slightly from a typical pharmacy. However, the primary function of a compounding pharmacy is to create medications that are recommended by a doctor in accordance with the individual needs of each patient. It involves creating a medication's customized formulation to meet a patient's particular demands, which cannot be satisfied by commercially accessible medications. This may be done for medical purposes, such as to deliver the medication in a new way (for example, switching from a tablet to a liquid), to avoid a non-active ingredient to which the patient is allergic, or to administer a precise dose that isn't currently commercially accessible.

These custom-made medications are used for pain relief, dermatology, and hormone replacement therapy. Additionally, it can occasionally be utilized as a dietary supplement. The Compounding Pharmacies Market is anticipated to be driven by the increasing number of patent expirations, increased life expectancy, and the growing elderly population. Additionally, it is anticipated that the rising drug failure rate and the increased public awareness of the advantages of compounded medications will fuel the market.

FutureWise Market Research has published a report that provides an insightful analysis of compounding pharmacy market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. FutureWise Market Research has published a report that provides an insightful analysis of Compounding Pharmacy market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.

According to the analysis conducted by FutureWise research analysts, the compounding pharmacy market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.
  • B. Braun Medical
  • Dougherty's Pharmacy
  • Fagron
  • Fresenius Kabi
  • Institutional Pharmacy Solutions
  • Clinigen Group PLC
  • Lorraine’s Pharmacy
  • McGuff Company
  • Pencol Compounding Pharmacy
  • Athenex Pharma Solutions (Athenex Inc.)
  • Rx3 Compounding Pharmacy
  • Triangle Compounding Pharmacies
  • Nephron Pharmaceuticals Corporation
  • Wedgewood Village Pharmacy, Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent development by key players in compounding pharmacy market:

In July 2022- Fagron purchased a 503B outsourcing facility in Boston from Fresenius Kabi. The Fagron sterile compounding network has grown throughout the United States.

Due to increasing medical drug shortages worldwide, rising costs of branded prescription alternatives, and restricted drug accessibility, the compound pharmaceutical market is predicted to grow. The need for compounding pharmacies will grow as drug failure rates rise. The market will develop due to more individuals adopting these personalized treatments and becoming more aware of the benefits of compounded pharmaceuticals. Moreover, the growing vulnerability of older persons to chronic conditions like cardiovascular disease has resulted in a large increase in the demand for specialized therapies over time. Compounding pharmacies are a special kind of pharmacy that creates personalized drugs in response to each patient's particular needs. It also allows simple administration of drugs via transdermal patches, lollipops, and others. Patients with serious illnesses like cancer who are unable to swallow a medication can benefit from compound pharmacy medications. The increased use of compound pharmacies for chronic illness is anticipated to expand the revenue of this target medicine. However, the same safety, quality, and effectiveness guarantees in authorized pharmaceuticals are not present in compounded medications, despite the fact that they can help patients with serious medical needs. Patients who take compounded drugs are unnecessarily exposed to possibly harmful health risks. Compound drugs are not FDA-approved; thus, the FDA does not evaluate their effectiveness, quality, or safety before putting them on the market. Furthermore, sloppy compounding techniques can result in serious drug quality problems like contamination or a drug with too much of an active ingredient. This could lead to severe patient injury or even death. The factors mentioned above are expected to constrain the market growth.

By Therapeutic Area

  • Hormone Replacement
  • Pain Management
  • Dermatology applications
  • Specialty drugs
  • Nutritional supplements
  • Others

By Product

  • Oral
    •    Solid preparations
      •         Tablets
      •         Capsules
      •        Granules
      •         Powder
      •         Others
    •    Liquid preparations
      •         Solutions
      •         Suspension
      •         Emulsion
      •         Syrup
      •         Others
  • Topical
    •    Ointments
    •    Creams
    •    Gels
    •    Pastes
    •    Others
  • Rectal
    •    Suppositories
    •    Enema
    •    Others
  • Parenteral
    •    LVP
    •    SVP
  • Nasal
  • Ophthalmic
  • Otic

By Application

  • Children
  • Adult
  • Geriatric
  • Veterinary

 By Compounding Type

  • Pharmaceutical Ingredient Alteration (PIA)
  • Currently Unavailable Pharmaceutical Manufacturing (CUPM)
  • Pharmaceutical Dosage Alteration (PDA)
  • Others

By Sterility

  • Sterile dosage form
  • Non-sterile dosage forms

By Distribution Channels

  • Hospital pharmacy
  • Compounding pharmacies
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. The existence of several compounding pharmacies, strong consumer uptake, and the scarcity of many medications are essential drivers of market expansion. There are currently roughly 56,000 compounding pharmacies in operation in the United States, of which 7,500 pharmacies offer advanced compounding services, according to statistics released by the International Academy of Compounding Pharmacists (IACP) in October 2021. The Food and Drug Administration (FDA) of the United States offers regulations for preserving the quality of medicines. Additionally, each state has its laws and rules governing the operation of a compounding pharmacy. As a result, these rules increase patients' trust in compounding pharmacies and are anticipated to boost their demand over the projection period.

Additionally based on product; oral holds highest market share followed by therapeutic area; in which hormone replacement segment dominates the market in 2022.
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Compounding Pharmacy Market By Therapeutic Area, By Product, By Application, By Compounding Type, By Sterility, By Distribution Channels and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- End-Users launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com.

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Usageology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Compounding Pharmacy Market Variables, Trends and Scope

    •        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Compounding Pharmacy Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Compounding Pharmacy Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Compounding Pharmacy Market, By Therapeutic Area Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Hormone Replacement
        2. Pain Management
        3. Dermatology applications
        4. Specialty drugs
        5. Nutritional supplements
        6. Others

  • 8.   Global Compounding Pharmacy Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Oral
         1.1. Solid preparations
          1.1.1. Tablets
          1.1.2. Capsules
          1.1.3. Granules
          1.1.4. Powder
          1.1.5. Others
         1.2. Liquid preparations
          1.2.1. Solutions
          1.2.2. Suspension
          1.2.3. Emulsion
          1.2.4. Syrup
          1.2.5. Others
        2. Topical
         2.1. Ointments
         2.2. Creams
         2.3. Gels
         2.4. Pastes
         2.5. Others
        3. Rectal
         3.1. Suppositories
         3.2. Enema
         3.3. Others
        4. Parenteral
         4.1. LVP
         4.2. SVP
        5. Nasal
        6. Ophthalmic
        7. Otic

  • 9.   Global Compounding Pharmacy Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Children
        2. Adult
        3. Geriatric
        4. Veterinary

  • 10.   Global Compounding Pharmacy Market, By Compounding Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Pharmaceutical Ingredient Alteration (PIA)
        2. Currently Unavailable Pharmaceutical Manufacturing (CUPM)
        3. Pharmaceutical Dosage Alteration (PDA)
        4. Others

  • 11.   Global Compounding Pharmacy Market, By Sterility Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Sterile dosage form
        2. Non-sterile dosage forms

  • 12.   Global Compounding Pharmacy Market, By Distribution Channels Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Hospital pharmacy
        2. Compounding pharmacies
        3. Others

  • 13.   North America Compounding Pharmacy Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 14.   Latin America Compounding Pharmacy Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 15.   Europe Compounding Pharmacy Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 16.   Asia Pacific Compounding Pharmacy Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031  

  • 17.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 18.   Market Share Analysis and Competitive Landscape

    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 19.   Company Profiles (Competition Dashboard, Competitors Deep Dive, End-Userss Offered and Financial Layouts)

    •   1. B. Braun Medical
           1.1. Company Overview
           1.2. Product Portfolio
           1.3. SWOT Analysis
           1.4. Financial Overview
           1.5. Strategic Overview
        2. Dougherty's Pharmacy
           2.1. Company Overview
           2.2. Product Portfolio
           2.3. SWOT Analysis
           2.4. Financial Overview
           2.5. Strategic Overview
        3. Fagron
           3.1. Company Overview
           3.2. Product Portfolio
           3.3. SWOT Analysis
           3.4. Financial Overview
           3.5. Strategic Overview
        4. Fresenius Kabi
           4.1. Company Overview
           4.2. Product Portfolio
           4.3. SWOT Analysis
           4.4. Financial Overview
           4.5. Strategic Overview
        5. Institutional Pharmacy Solutions
           5.1. Company Overview
           5.2. Product Portfolio
           5.3. SWOT Analysis
           5.4. Financial Overview
           5.5. Strategic Overview
        6. Clinigen Group PLC
           6.1. Company Overview
           6.2. Product Portfolio
           6.3. SWOT Analysis
           6.4. Financial Overview
           6.5. Strategic Overview
        7. Lorraine’s Pharmacy
           7.1. Company Overview
           7.2. Product Portfolio
           7.3. SWOT Analysis
           7.4. Financial Overview
           7.5. Strategic Overview
        8. McGuff Company
           8.1. Company Overview
           8.2. Product Portfolio
           8.3. SWOT Analysis
           8.4. Financial Overview
           8.5. Strategic Overview
        9. Pencol Compounding Pharmacy
           9.1. Company Overview
           9.2. Product Portfolio
           9.3. SWOT Analysis
           9.4. Financial Overview
           9.5. Strategic Overview
        10. Athenex Pharma Solutions (Athenex Inc.)
           10.1. Company Overview
           10.2. Product Portfolio
           10.3. SWOT Analysis
           10.4. Financial Overview
           10.5. Strategic Overview
        11. Rx3 Compounding Pharmacy
           11.1. Company Overview
           11.2. Product Portfolio
           11.3. SWOT Analysis
           11.4. Financial Overview
           11.5. Strategic Overview
        12. Triangle Compounding Pharmacies
           12.1. Company Overview
           12.2. Product Portfolio
           12.3. SWOT Analysis
           12.4. Financial Overview
           12.5. Strategic Overview
        13. Nephron Pharmaceuticals Corporation
           13.1. Company Overview
           13.2. Product Portfolio
           13.3. SWOT Analysis
           13.4. Financial Overview
           13.5. Strategic Overview
        14. Wedgewood Village Pharmacy, Inc.
           14.1. Company Overview
           14.2. Product Portfolio
           14.3. SWOT Analysis
           14.4. Financial Overview
           14.5. Strategic Overview

  • 20.   Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
          5. The overall economic slowdown of the developing and developed nations

  • 21.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11